as well as Eli Lilly’s donanemab, which has been submitted for approval and is heading for an FDA advisory committee meeting. In addition, Roche and Lilly hope it could be deployed to accelerate ...
Wall Street will navigate a series of data releases tied to inflation this week as bond markets continue their months-long selloff.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results